UP!
| 2016-07-08 | Reiterated Rating | Maxim Group | Buy | $7.00 to $9.00 |
| 2016-05-17 | Reiterated Rating | FBR & Co. | Outperform | $13.00 |
| 2016-05-17 | Reiterated Rating | FBR & Co | Outperform | $13.00 |
| 2016-04-30 | Reiterated Rating | Morgan Stanley | Hold | |
| 2016-04-30 | Reiterated Rating | Cowen and Company | Hold | |
| 2016-04-29 | Reiterated Rating | FBR & Co. | Buy | $13.00 |
| 2016-03-30 | Boost Price Target | FBR & Co. | Outperform | $10.00 to $13.00 |
| 2016-03-29 | Reiterated Rating | BTIG Research | Sell | $2.50 |
| 2016-03-29 | Reiterated Rating | Maxim Group | Buy | $5.00 to $7.00 |
| 2016-03-28 | Reiterated Rating | Cowen and Company | Hold | |
| 2016-03-09 | Lower Price Target | JMP Securities | Market Outperform | $19.00 to $16.00 |
| 2016-02-29 | Upgrade | FBR & Co. | Market Perform to Outperform | $10.00 |
| 2016-02-26 | Boost Price Target | Stifel Nicolaus | Buy | $9.00 to $10.00 |
| 2016-02-26 | Upgrade | Raymond James | Market Perform to Outperform | $6.00 |
| 2016-02-26 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | |
| 2016-02-26 | Reiterated Rating | Brean Capital | Buy | $18.00 to $10.00 |
| 2016-02-26 | Upgrade | Raymond James Financial Inc. | Market Perform to Outperform | $6.00 |
| 2016-02-25 | Reiterated Rating | Maxim Group | Buy | $11.00 to $5.00 |
| 2016-02-19 | Lower Price Target | Citigroup Inc. | $2.50 to $1.80 | |
| 2016-01-13 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $11.00 |
| 2015-10-19 | Reiterated Rating | FBR & Co. | Hold | $10.00 |
| 2015-10-16 | Reiterated Rating | JPMorgan Chase & Co. | Buy | $16.00 |
| 2015-10-16 | Reiterated Rating | Maxim Group | Buy | $11.00 |
| 2015-10-05 | Upgrade | Morgan Stanley | Underweight to Equal Weight | $3.00 |
| 2015-09-25 | Reiterated Rating | JPMorgan Chase & Co. | Buy | $17.00 to $16.00 |
| 2015-09-25 | Reiterated Rating | Citigroup Inc. | Sell | $1.50 |
| 2015-09-25 | Reiterated Rating | Maxim Group | Buy | $11.00 |
| 2015-09-24 | Reiterated Rating | Cowen and Company | Hold | |
| 2015-09-24 | Reiterated Rating | BTIG Research | Sell | $3.50 to $2.50 |
| 2015-09-24 | Reiterated Rating | Brean Capital | Buy | $22.00 to $18.00 |
| 2015-09-09 | Initiated Coverage | Raymond James | Market Perform | |
| 2015-09-04 | Reiterated Rating | Brean Capital | Buy | $22.00 |
| 2015-09-03 | Initiated Coverage | Citigroup Inc. | Sell | |
| 2015-08-13 | Initiated Coverage | Morgan Stanley | Underweight | $3.00 |
| 2015-08-11 | Initiated Coverage | FBR & Co. | Market Perform | $10.00 |
| 2015-08-10 | Downgrade | Roth Capital | Buy to Neutral | $11.00 to $6.00 |
| 2015-08-07 | Reiterated Rating | MLV & Co. | Buy | $25.00 |
| 2015-08-06 | Reiterated Rating | JPMorgan Chase & Co. | Buy | $19.00 to $17.00 |
| 2015-08-06 | Downgrade | BTIG Research | Neutral to Sell | $3.50 |
| 2015-08-06 | Reiterated Rating | Maxim Group | Buy | $17.00 to $11.00 |
| 2015-07-25 | Reiterated Rating | Maxim Group | Buy | |
| 2015-07-23 | Lower Price Target | Roth Capital | Buy | $23.00 to $11.00 |
| 2015-07-23 | Downgrade | Cowen and Company | Outperform to Market Perform | |
| 2015-06-25 | Reiterated Rating | Roth Capital | Buy | $23.00 |
| 2015-06-25 | Reiterated Rating | MLV & Co. | Buy | $25.00 |
| 2015-06-24 | Reiterated Rating | Maxim Group | Buy | $17.00 |
| 2015-06-24 | Set Price Target | Brean Capital | Buy | $26.00 |
| 2015-05-09 | Reiterated Rating | Brean Capital | Buy | $26.00 |
| 2015-05-09 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $19.00 |
| 2015-05-06 | Lower Price Target | Mizuho | Buy | $25.00 to $21.00 |
| 2015-05-05 | Lower Price Target | Maxim Group | Buy | $32.00 to $17.00 |
| 2015-05-05 | Lower Price Target | Roth Capital | Buy | $27.00 to $23.00 |
| 2015-04-20 | Lower Price Target | Stifel Nicolaus | Buy | $19.00 to $17.00 |
| 2015-03-20 | Lower Price Target | Oppenheimer | Outperform | $22.00 to $18.00 |
| 2015-03-20 | Lower Price Target | Oppenheimer Holdings Inc. | Outperform | $22.00 to $18.00 |
| 2015-03-02 | Lower Price Target | Stifel Nicolaus | Buy | $22.00 to $19.00 |
| 2015-02-27 | Reiterated Rating | BTIG Research | Hold | |
| 2015-02-27 | Lower Price Target | Roth Capital | Buy | $32.00 to $27.00 |
| 2015-02-09 | Set Price Target | Cowen and Company | Buy | $25.00 |
| 2015-02-03 | Lower Price Target | Mizuho | Buy | $30.00 to $25.00 |
| 2015-01-26 | Set Price Target | Brean Capital | Buy | $26.00 |
| 2015-01-07 | Set Price Target | MLV & Co. | Buy | $21.00 to $25.00 |
| 2015-01-06 | Initiated Coverage | BTIG Research | Neutral | |
| 2014-12-22 | Set Price Target | Maxim Group | Buy | $32.00 |
| 2014-12-05 | Initiated Coverage | Cowen and Company | Outperform | |
| 2014-12-02 | Reiterated | FBR Capital | Underperform | |
| 2014-12-02 | Reiterated Rating | FBR & Co. | Underperform | |
| 2014-11-28 | Boost Price Target | Maxim Group | Buy | $26.00 to $32.00 |
| 2014-11-17 | Lower Price Target | FBR & Co. | Underperform | $14.00 to $12.00 |
| 2014-11-06 | Reiterated Rating | Roth Capital | Positive | |
| 2014-09-22 | Initiated Coverage | Oppenheimer | Outperform | $22.00 |
| 2014-09-08 | Downgrade | FBR Capital | Mkt Perform to Underperform | |
| 2014-09-08 | Downgrade | FBR & Co. | Market Perform to Underperform | |
| 2014-09-08 | Boost Price Target | Roth Capital | Market Perform to Buy | $30.00 to $32.00 |
| 2014-08-26 | Reiterated Rating | Maxim Group | Buy | |
| 2014-08-13 | Initiated Coverage | FBR & Co. | Market Perform | $16.00 |
| 2014-08-08 | Lower Price Target | Mizuho | $32.00 to $30.00 | |
| 2014-05-23 | Reiterated | H.C. Wainwright | Buy | $19 |
| 2014-05-23 | Reiterated Rating | HC Wainwright | Buy | $19.00 |
| 2014-05-12 | Lower Price Target | MLV & Co. | Buy | $27.00 to $21.00 |
| 2014-05-09 | Lower Price Target | Mizuho | $34.00 to $32.00 | |
| 2014-05-09 | Lower Price Target | JMP Securities | $25.00 to $19.00 | |
| 2014-04-04 | Boost Price Target | Ladenburg Thalmann | Buy | $24.00 to $30.00 |
| 2014-04-02 | Reiterated Rating | HC Wainwright | Buy | |
| 2014-04-02 | Boost Price Target | Mizuho | Buy | $25.00 to $34.00 |
| 2014-04-01 | Boost Price Target | Oppenheimer | Outperform | $20.00 to $22.00 |
| 2014-03-21 | Initiated | Mizuho | Buy | $25 |
| 2014-03-20 | Initiated Coverage | Mizuho | Buy | $25.00 |
| 2014-03-14 | Reiterated | Stifel | Buy | $17 to $19 |
| 2014-03-14 | Reiterated Rating | JMP Securities | Outperform | $25.00 |
| 2014-03-14 | Boost Price Target | Stifel Nicolaus | Buy | $17.00 to $19.00 |
| 2014-01-27 | Boost Price Target | Maxim Group | Buy | $16.00 to $25.00 |
| 2014-01-21 | Boost Price Target | Roth Capital | $30.00 | |
| 2013-11-07 | Reiterated Rating | JPMorgan Chase & Co. | Positive | |
| 2013-11-05 | Reiterated Rating | Brean Capital | Buy | |
| 2013-11-04 | Reiterated Rating | JMP Securities | Outperform | $14.00 to $22.00 |
| 2013-10-17 | Boost Price Target | Ladenburg Thalmann | Buy | $15.00 to $19.00 |
| 2013-10-16 | Set Price Target | Brean Capital | Positive | $20.00 |
| 2013-10-16 | Boost Price Target | Roth Capital | $24.00 | |
| 2013-08-01 | Reiterated | Maxim Group | Buy | $9 to $12 |
| 2013-01-29 | Reiterated | Stifel Nicolaus | Buy | $4 to $13 |
| 2013-01-29 | Reiterated | MLV & Co | Buy | $5 to $15 |
| 2013-01-29 | Reiterated | Ladenburg Thalmann | Buy | $5 to $15 |
| 2013-01-29 | Reiterated | Burrill Institutional Research | Mkt Outperform | $6 to $11 |
| 2013-01-28 | Reiterated | Maxim Group | Buy | $4 to $9 |
| 2012-12-13 | Initiated | Maxim Group | Buy | $4 |
| 2012-11-13 | Initiated | Burrill Institutional Research | Mkt Outperform | $6 |
| 2012-10-10 | Reiterated | Ladenburg Thalmann | Buy | $3 to $5 |
| 2016-07-08 | Reiterated Rating | Maxim Group | Buy | $7.00 to $9.00 |
| 2016-05-17 | Reiterated Rating | FBR & Co. | Outperform | $13.00 |
| 2016-05-17 | Reiterated Rating | FBR & Co | Outperform | $13.00 |
| 2016-04-30 | Reiterated Rating | Morgan Stanley | Hold | |
| 2016-04-30 | Reiterated Rating | Cowen and Company | Hold |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In KERX 12 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 2.62M |
| BlackRock Fund Advisors | 2.37M |
| MANAGED ACCOUNT ADVISORS LLC | 0.64M |
| BlackRock Investment Management, LLC | 0.29M |
| EverPoint Asset Management, LLC | 60000 |
| BlackRock Group LTD | 55363 |
| BLACKROCK ADVISORS LLC | 44545 |
| CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. | 41500 |
| KCG Holdings, Inc. | 11335 |
| Placemark Investments, Inc. | 10199 |
| FNY Managed Accounts LLC | 15 |
| HUNTINGTON NATIONAL BANK | 1 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| WEISS MICHAEL S | 1.44% (1320418) | CNDO / KERX / TGTX / |
| BENTSUR RON Chief Executive Officer | 0.85% (777209) | KERX / STML / |
| Madison Greg EVP and COO | 0.62% (566586) | AMAG / KERX / |
| Tarnok Michael P. | 0.37% (338600) | KERX / |
| Oliviero James F III Chief Financial Officer | 0.23% (209406) | KERX / |
| Fowler Wyche JR | 0.19% (175000) | KERX / |
| Holmes Scott A Chief Financial Officer | 0.19% (170062) | AMAG / KERX / |
| Cameron Kevin J | 0.19% (170000) | KERX / |
| Neylan John F. Chief Medical Officer | 0.17% (154314) | KERX / |
| Adams Brian VP and General Counsel | 0.14% (126069) | KERX / |
| FECZKO JOSEPH M | 0.13% (120000) | CCXI / KERX / |
| Carberry Christine A. Chief Operating Officer | 0.13% (115176) | KERX / |
| Kaye Jack | 0.09% (85000) | KERX / QURE / |
| Regan Daniel Paul | 0.05% (50000) | ICPT / KERX / |
| ROGERS MICHAEL W | 0.02% (20000) | ACOR / BGMD / CNDO / KERX / PSDV / |
| GILMAN STEVEN C | 0.02% (20000) | ASTM / CBST / CFRX / KERX / MNTA / SCYX / |
| Butler John P. | 0.02% (20000) | AKBA / KERX / RLYP / |
| Heffernan Michael Thomas | 0.01% (10000) | CRTX / KERX / |
| Morrison Jodie Pope | 0.01% (10000) | KERX / TKAI / |
UM